Literature DB >> 22939103

Daytime REM sleep in Parkinson's disease.

Donald L Bliwise1, Lynn Marie Trotti, Jorge J Juncos, Stewart A Factor, Alan Freeman, David B Rye.   

Abstract

BACKGROUND: Previous studies have demonstrated both clinical and neurochemical similarities between Parkinson's disease (PD) and narcolepsy. The intrusion of REM sleep into the daytime remains a cardinal feature of narcolepsy, but the importance of these intrusions in PD remains unclear. In this study we examined REM sleep during daytime Maintenance of Wakefulness Testing (MWT) in PD patients.
METHODS: Patients spent 2 consecutive nights and days in the sleep laboratory. During the daytime, we employed a modified MWT procedure in which each daytime nap opportunity (4 per day) was extended to 40 min, regardless of whether the patient was able to sleep or how much the patient slept. We examined each nap opportunity for the presence of REM sleep and time to fall asleep.
RESULTS: Eleven of 63 PD patients studied showed 2 or more REM episodes and 10 showed 1 REM episode on their daytime MWTs. Nocturnal sleep characteristics and sleep disorders were unrelated to the presence of daytime REM sleep, however, patients with daytime REM were significantly sleepier during the daytime than those patients without REM. Demographic and clinical variables, including Unified Parkinson's Disease Rating Scale motor scores and levodopa dose equivalents, were unrelated to the presence of REM sleep.
CONCLUSIONS: A sizeable proportion of PD patients demonstrated REM sleep and daytime sleep tendency during daytime nap testing. These data confirm similarities in REM intrusions between narcolepsy and PD, perhaps suggesting parallel neurodegenerative conditions of hypocretin deficiency.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22939103      PMCID: PMC3516626          DOI: 10.1016/j.parkreldis.2012.08.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  31 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

3.  Core assessment program for intracerebral transplantations (CAPIT).

Authors:  J W Langston; H Widner; C G Goetz; D Brooks; S Fahn; T Freeman; R Watts
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

4.  Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence.

Authors:  M M Mitler; K S Gujavarty; C P Browman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-06

5.  Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.

Authors:  Donald L Bliwise; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Cathy Wood-Siverio; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

6.  Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.

Authors:  Ajmal Razmy; Anthony E Lang; Colin M Shapiro
Journal:  Arch Neurol       Date:  2004-01

7.  Daytime sleepiness and alertness in patients with Parkinson disease.

Authors:  Suzanne Stevens; Cynthia L Cormella; Edward J Stepanski
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Case control polysomnographic studies of sleep disorders in Parkinson's disease.

Authors:  Ming-Hui Yong; Stephanie Fook-Chong; Ratnagopal Pavanni; Li-Ling Lim; Eng-King Tan
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

10.  Hypocretin (orexin) cell loss in Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-05-09       Impact factor: 13.501

View more
  6 in total

Review 1.  Disturbances of Sleep and Alertness in Parkinson's Disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

Review 2.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

Review 3.  Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide.

Authors:  Christian R Baumann
Journal:  J Neural Transm (Vienna)       Date:  2019-06-29       Impact factor: 3.575

4.  Cortical Phase-Amplitude Coupling in a Progressive Model of Parkinsonism in Nonhuman Primates.

Authors:  Annaelle Devergnas; M Caiola; D Pittard; T Wichmann
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

5.  Behavioral validation of the University of Michigan REM behavior disorder questionnaire in the synucleinopathies.

Authors:  Alex M Dworetz; Lynn Marie Trotti; Donald L Bliwise
Journal:  J Neurol Sci       Date:  2022-03-05       Impact factor: 4.553

Review 6.  Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.

Authors:  Yun Shen; Jun-Ying Huang; Jie Li; Chun-Feng Liu
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.